MedTrace Logo

Clinical Learning Study for a Mobile Smoking Cessation Program

NCT04857515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2021-08-17

No results posted yet for this study

Summary

The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cessation.

Conditions

  • Smoking Cessation
  • Smoking Behaviors
  • Smoking Reduction
  • Smoking, Cigarette
  • Smoking
  • Nicotine Dependence

Interventions

DEVICE

Clickotine®

Clickotine is a DTx that contains behavior modification techniques that include controlled breathing, social engagement, personalized messaging, medication access and adherence, digital diversions, and financial incentives.

Sponsors & Collaborators

  • Click Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-12
Primary Completion
2021-06-28
Completion
2021-06-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04857515 on ClinicalTrials.gov